Pharmacovigilance specialists use the latest technologies, combined
with their expertise on the product and its therapeutic area, to
ensure a favourable benefit-risk profile of our products.
Our current team is made up of approximately 100 professionals with
various backgrounds, including medical doctors, veterinarians,
pharmacists, and biologists.
Through analysis of safety data - primarily side effect cases - our
team works to identify any clusters or trends that are occurring from
the use of Novo Nordisk products. They then medically evaluate these
cases, to determine if the side effect is related to our product, the
patient’s existing disease or other products the patient is taking.
Their findings are then presented to a committee of senior experts,
where the data will be challenged and validated. During audits and
inspections, specialists are expected to take the lead on answering
questions and providing any necessary information.
Specialists are responsible for contributing to several scientific
documents – including the clinical risk management plan (RMP) – which
is required during the marketing authorisation and clinical trial